Skip to main content

Table 4 cross validation results

From: Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of alzheimer's disease

  

Predicted

  

NC

AD

Original

NC

90%

10%

 

AD

20%

80%

  1. 85% of cross-validated cases correctly classified